Asacol 800mg MR Tablets Dosed At 4.8g Day Herald Fast Symptom Relief And Improved Quality Of Life For Moderately Active UC Patients
Procter & Gamble Pharmaceuticals (NYSE: P&G) announced that Asacol(R) (mesalazine) 800mg Modified Release (MR) tablets are now available in the UK for the treatment of mild to moderate acute exacerbations of ulcerative colitis (UC), and the maintenance of remission in UC and Crohn's ileo-colitis patients.
Improved Treatment For Crohn's Disease
An international research study, published in The Lancet, has thrown into question the current method of treating Crohn's disease - opening the door to a safer and more effective treatment option for sufferers of the chronic disease."Our study clearly demonstrated that this alternative treatment method was more effective at inducing disease remission than the conventional method, " said Dr.
Inflammatory Bowel Disease May Mimic Gynecological Disorders In Its Clinical Presentation
Endometriosis is a condition of unknown etiology in which endometrial tissue occurs at extra-uterine sites, including ovaries, fallopian tubes, and gastrointestinal tract. It usually occurs between 30 and 40 years of age. Four to 17% of menstruating women develop endometriosis.
New Treatment Strategy For Crohn's Disease Shows Promise
When treating patients with Crohn's disease, early use of an intensivecombined immunosuppression (CI) in combination withconventional management is more effective than the current standard, treatment with corticosteroids. These outcomes were reported in anArticle in the February 23, 2008 issue of The Lancet.
Early Data On Cimzia reg; Shows Promise In Crohn's Patients Without Infliximab
Datafrom the WELCOME trial presented at the third congress of the EuropeanCrohn's and Colitis Organisation (ECCO) show that, at the six weekmark, Cimzia (certolizumab pegol) is effective in Crohn's patientsshowing intolerance or no response to infliximab.
Hope For Crohn's Patients With Fistulas Found In HUMIRA Adalimumab
At the recent European Crohn's and Colitis Organization (ECCO) annualmeeting in Lyon, France, Abbott Laboratories announced that HUMIRA(Adalimumab) is successful in the treatment of fistulas in susceptibleCrohn's patients. Crohn'sDisease (CD) is a gastrointestinal disorder which is indicated bychronicinflammation of the wall of the digestive tract.
Caspase-12: MUHC Researcher Finds New Defense Mechanism Against Intestinal Inflammation
The body's first line of defence against pathogenic bacteria that we ingest may not be the immune system but rather the cells that line the intestine. This surprising conclusion is just one facet of a study by Dr. Maya Saleh, a researcher at the Research institute of the McGill University Health Centre, published in the journal Cell Host & Microbe on March 12.
Food For Life Baking Co., Inc. Recalls Spelt Bread , California - Product Contains Undeclared Wheat
Food For Life Baking Company of Corona, California is voluntarily recalling 2, 241 cases of Spelt Bread (UPC# 07347200168) because they contain spelt grain which is known to be a hybrid of wheat. People who have allergies to wheat or those with Celiac Disease may run the risk of a serious or life threatening allergic reaction if they consume spelt products.
CHMP Upholds Negative Opinion For The EU Application For Cimzia reg; In The Treatment Of Crohn's Disease
UCB announced today that the European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) has rejected the appeal following CHMP refusal of the Marketing Authorization Application (MAA) for Cimzia (certolizumab pegol) in the treatment of patients with Crohn's disease, a chronic and debilitating inflammatory disease.
CHMP Upholds Negative Opinion For The EU Application For Cimzia R In The Treatment Of Crohn's Disease
UCB announced that the European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) has rejected the appeal following CHMP refusal of the Marketing Authorization Application (MAA) for Cimzia (certolizumab pegol) in the treatment of patients with Crohn's disease, a chronic and debilitating inflammatory disease.